Stuttgart, Germany – December, 2014 – Impulse Dynamics announced the first implantation of its Optimizer IVs device in Russia.  The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF).  The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses. The implantation took place in Novosibirsk, Russia on 30 December 2014 by Prof. Evgeny Pokushalov, Deputy Director, Head of Interventional Cardiology Center, State Research Institute of Circulation Pathology.  Prof. Pokushalov said:  “I am pleased to provide the CCM therapy to patient with Heart Failure in Russia. This therapy addresses a major unmet clinical need to improve performance and daily life of patients with Chronic Heart Failure as there are currently no other device-based options for this large group of heart failure patients that are not adequately controlled with pharmaceutical treatment alone.”

“We are very pleased to be able to add Russia and China to the list of countries that offer the CCM therapy, delivered by the Optimizer device, to its patients” said Professor Shlomo Ben-Haim, MD, D.Sc, Founder and Chairman of Impulse Dynamics.  “CCM is a technology that meets a major need globally, and we are committed to expanding its introduction through healthcare systems worldwide to benefit more patients with heart failure.